The synthesis of novel 1,2,3-triazole-hydrazone derivatives embedded with 3,4-dimethoxy pyridine ring nucleus is described. These derivatives were prepared utilizing, 2-(chloromethyl)-3,4-dimethoxypyridine 1, 4-ethynylbenzaldehye 5 and various benzohydrazides7a-7j. The structures of the newly synthesized 1,2,3-triazole-hydrazones 8a-j was established on the basis of the spectroscopic techniques like 1 H NMR, mass and IR data. They were evaluated against a panel of bacterial and fungal pathogens such as Staphylococcus. pyogens, Staphylococcus. Aureus (Gram positive bacteria), Escherichia.coli, Pseudomonas. aeruginosa (Gram negative bacteria) and Aspergillus niger and Candida albicans (Fungal stains). Compounds 8b, 8c, 8d, 8e and 8f with R = 4-OH, 4-OMe, 4-SO 2 Me, 3,45,-OMe and 3-NO 2 respectively showed moderate antibacterial activity while compounds 8b, 8d, 8i and 8j with R = 4-OH, 4-SO 2 Me, 3,5-dichloro and 2,5-difluoro substitution exhibited very good fungal activity.
INTRODUCTION
The growth of 1,2,3-triazoles for drug discovery and industrial use has been shown to be very resourceful.The interest in the 1,2,3-triazole is due to it being non-toxic, benign and stable. Triazoles are predominantly attractive for medicinal use because they are more expected to be water soluble than normal aromatic compounds, and are stable in biological systems 1 .These triazole products readily connect with biological targets, through hydrogen bonding and dipole interactions 2 . Some of the pharmaceutically prominent triazole antifungal drugs are fluconazole 3 , isavuconazole 4 , itraconazole 5 , voriconazole 6 , pramiconazole 7 , and posaconazole 8 . Also, the examples of triazole crop protection fungicides includesepoxiconazole 9 , triadimenol 10 , propiconazole 11 , metconazole 12 , cyproconazole 13 , tebuconazole 14 , flusilazole 15 and paclobutrazol 16 . Derivatives of 1,2,3-triazole have been found to have anti-HIV 17 , anti-allergenic 18 , cytostatic 19 , virostatic 20 , anti-inflammatory 21 activities, furthermore, these triazoles are also being studied for the treatment of obesity 22 and anti-oxidant activity 23 .
Hydrazone derivatives of heteroaromatic compounds have also been reported to possess anti-inflammatory 24, 25 , anticancer 26 , antitumor 27 , antibacterial or plant-growth activity 28, 29 .
The frequency of bacterial and fungal infections is an important contemporary problem due to the emerging new infectious diseases and increasing multi-drug resistance of microbial pathogens 30 . The widespread use of antibiotics has contributed to the growing infection rate since fungal infections occur after antibiotic therapy, which has the effect of killing the beneficial bacteria that normally suppress fungi. The development of new effective antifungal and antibacterial agents is strongly needed. Herein, we report the synthesis and antimicrobial evaluation of new 1,2,3 triazole derivatives linked with pyridine and hydrazone fragments. The structures of the synthesized compounds were determined by 1H NMR, mass and IR spectroscopy.
RESULTS AND DISCUSSION

Chemistry
The synthesis of new (E)-N'-(4-(1-((3,4-dimethoxypyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl) benzylidene)benzohydrazide derivatives is illustrated in Scheme-1. 4 . De-protection of the trimethylsillyl group in presence of K 2 CO 3 in methanol resulted in the desired benzaldehyde 5 .
The str uctures of the synthesized compounds were confirmed by 1 H NMR, Mass and IR data. As a representative example, the 1 H NMR spectra of (E)-N'-(4-(1-((3,4-dimethoxypyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)benzylidene)-4-methoxybenzohydrazide is as follows, the protons resonating at 11.78 ppm and 8.48 ppm as broad singlet corresponds to the characteristic -CONH and -CH=N-respectively, while the protons resonating at 8.72 ppm (pyridine ring proton) and 7.23 ppm (overlap of triazole and pyridine ring proton signal), is assigned to triazole ring and pyridine ring protons. The multiplet at 7.94-7.91 ppm (four proton integration), a broad singlet at 7.81 ppm (two proton integration) and a doublet at 7.07 ppm (two proton integration is assigned to the protons of the 4-methoxy phenyl ring and the phenyl ring flanked to triazole ring. The aliphatic protons are observed in the expected region. The mass and IR spectral data of the hydrazone compounds are in agreement with the desired structures.
Antibacterial and antifungal activity
The screening results of (E)-N'-(4-(1-((3,4-dimethoxypyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl) benzylidene)benzohydrazide derivatives 8a-j are tabulated in table 1. From table-1 it is observed that hydrazone derivatives 8b, 8c, 8d, 8e and 8f with R = 4-OH, 4-OMe, 4-SO 2 Me, 3,4,5,-OMe and 3-NO 2 respectively showed moderate antibacterial activity while the hydrazone derivatives 8a, 8i and 8j with R = H, 3,5-dichloro and 2,5-difluoro showed weak antibacterial against both Gram positive and Gram negative bacteria with reference to ciprofloxacin as the standard drug.
In case of fungal screening evaluation, hydrazone derivatives 8b, 8d, 8i and 8j with R = 4-OH, 4-SO 2 Me, 3,5-dichloro and 2,5-difluoro substitution exhibited very good fungal activity and the remaining hydrazone derivatives in the series showed moderate antifungal activity against the tested fungal strains with reference to Greseofluvin as the standard drug. 
EXPERIMENTAL
The solvents were purified according to standard procedures prior to use, and all commercial chemicals were used as received. For thin-layer chromatography (TLC) analysis, Merck pre-coated plates (silica gel 60 F254) were used and spots were visualized with UV light. Merck silica gel 60 (230-400 mesh) was used for flash column chromatography and the eluting solvents are indicated in the procedures. Melting point (m.p.) determinations were performed by using Mel-temp apparatus and are uncorrected. 
2-(azidomethyl)-3,4-dimethoxypyridine 2
Sodium azide (0.365 g, 5.60 mmol) was added to a solution of compound 1(1g, 5.33 mmol) in DMF (5 mL) at room temperature. The reaction mixture was heated to 100°C for 1h. After completion of the reaction (by T.L.C), the reaction contents were cooled to room temperature and diluted with ethylacetate (15 mL) and water (5 mL). The organic layer was separated and washed with brine solution (2 X 5 mL), separated, dried over anhydrous sodium sulphate, filtered and concentrated under reduced pressure to obtain the crude compound 2. The crude compound was utilized in the next step without further purification.
4-(2-(trimethylsilyl)ethynyl)benzaldehyde 4
To a solution of 4-iodobenzaldehyde 3 (1g, 4.30 mmol) in tetrahydrofuran (12 mL), in a seal tube, were added sequentially, copper(I) iodide (0.14 mmol), triphenylphosphine (0.39 mmol), bis(triphenylphosphine)palladium(II) dichloride (0.14 mmol) and trimethylsilylacetylene (0.59 mL, 4.14 mmol) under argon atmosphere. After string 8a  12  11  9  10  20  18  8b  17  18  14  16  26  22  8c  16  17  12  14  22  17  8d  20  21  18  19  25  20  8e  20  22  17  17  19  16  8f  19  20  18  18  20  18  8g  ----21  19  8h  ----19  17  8i  12  11  9  10  26  22  8j  11  13  12  11  25  23  Ciprofloxacin  28  27  22  22  Greseofluvin  28  24 Standard drug concentration: 250µg/mL; "-_ No activity for 15 min, triethylamine (12.9 mmol) was added and the resultant mixture was heated at 65ÚC for 30 min. The reaction contents were diluted with ethyl acetate (15 mL), washed with water (2 X 15 mL), washed with brine solution (10 mL). The organic layer was separated and dried over Na 2 SO 4 . The solvent was evaporated under reduced pressure to obtain compound 4 as a viscous pale yellow oily liquid. The crude compound was utilized in the next step without further purification. 
4-ethynylbenzaldehyde 5
A mixture of 4-((trimethylsilyl)ethynyl) benzaldehyde 4 (1g, 4.94 mmol) and potassium carbonate (1g, 7.41 mmol) were stirred in methanol (25 mL) at room temperature for 1 hour. The reaction mixture was diluted with ethylacetate (20 mL) and washed with water (2 x 20 mL) followed by brine solution.
4-(1-((3,4-dimethoxypyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)benzaldehyde 6
4-ethynylbenzaldehyde 5 (1g, 7.68 mol) was added to a solution of compound 3 (0.67g, 5.15 mmol) in acetonitrile (10 mL) followed by the addition of CuI(10 mol %). The reaction mixture was heated to reflux for 1h. After completion of the reaction (monitored by T.L.C), the reaction mixture was diluted with ethylacetate (20 mL) and water (20 mL 
Experimental procedure for synthesis of benzohydrazides7a-j [34-35]
Benzoic acids a-j (8.12 mmol) was dissolved in ethanol (15 mL) and added catalytic qty of conc. H 2 SO 4 and heated to reflux for 10 h. Ethanol was evaporated and the obtained residue was diluted with ethylacetate (25 mL). The organic layer was washed with aqueous saturated NaHCO 3 (3 X 15 mL) followed by water (2 X 15 mL) and brine solution (20 mL). The organic layer was separated, dried over sodium sulphate, filtered and evaporated to obtain respective ethyl benzoates.
To the above prepared respective ethyl benzoates (6.65 mmol) in ethanol was added hydrazine-hydrate (40.0 mmol) and refluxed for 8 h. Ethanol was evaporated from the reaction mixture and the precipitated solids were slurred with petether (5 times) and filtered at the pump and dried to obtain benzohydrazides7a-7j.
General procedure for the synthesis of hydrazone derivatives 8a-8j
To a solution of compound 6 (100 mg, 0.308 mmol) in ethanol was added corresponding benzohydrazides 7a-7j (0.308 mmol) and heated to reflux for 30 min. The precipitated solids were filtered at the pump and dried to afford hydrazone derivatives 8a-8j in quantitative yields. N'-(4-(1-((3,4-dimethoxypyridin-2-yl)  methyl)-1H-1,2,3-triazol-4-yl) N'-(4-(1-((3,4-dimethoxypyridin-2-yl)  methyl)-1H-1,2,3-triazol-4-yl) (E)-N'-(4-(1-((3,4-dimethoxypyridin-2-yl)  methyl)-1H-1,2,3-triazol-4-yl) N'-(4-(1-((3,4-dimethoxypyridin-2-yl)  methyl)-1H-1,2,3-triazol-4-yl) N'-(4-(1-((3,4-dimethoxypyridin-2-yl)  methyl)-1H-1,2,3-triazol-4-yl) 
(E)-
( E )-N'-(4-(1-((3,4-dimethoxypyridin-2-yl) methyl)-1H-1,2,3-triazol-4-yl)benzylidene)-4-chlorobenzohydrazide 8h
Pale yellow solid; Yield: 86%; M. N'-(4-(1-((3,4-dimethoxypyridin-2-yl)  methyl)-1H-1,2,3-triazol-4-yl) N'-(4-(1-((3,4-dimethoxypyridin-2-yl)  methyl)-1H-1,2,3-triazol-4-yl) 
Antibacterial and antifungal bioassay
The antibacterial activity of all the hydrazone derivatives (8a-j) were examined against a panel of bacterial culture viz., Staphylococcus.pyogens, Staphylococcus.aureus (Gram positive) and Escherichia.coli, Pseudomonas.aeruginosa (Gram negative). The antibacterial activity was performed by agar well diffusion method with reference to Ciprofloxacin (250 µg/mL) as standard drug. Nutrient agar was used as culture media and DMSO was used as solvent control [36] [37] [38] . Similarly, the antifungal activity was evaluated Aspergillus niger and Candida albicans with reference to Nystatin as the standard antifungal drug. Sabouraud dextrose agar was used as culture media and DMF was used as solvent control 39 . The results of the antibacterial and antifungal activity was determined by measuring zone of inhibition and is tabulated Table 1 .
CONCLUSION
In summary, the present paper describes the synthesis of some new 1,2,3-triazole-benzohydrazides 8a-j in six steps involving condensation of the key intermediate 4-(1-((3,4-dimethoxypyridin-2-yl) methyl)-1H-1,2,3-triazol-4-yl)benzaldehyde 6 with various benzohydrazide7a-j in quatitative yields. The antifungal screening of these hydrazones revealed that compounds 8b, 8d, 8i and 8j with R = 4-OH, 4-SO 2 Me, 3,5-dichloro and 2,5-difluoro substitution exhibited very good fungal activity and the remaining hydrazone derivatives in the series showed moderate antifungal activity.
